A new resource on optimal management of injectable medicines for Australians with COVID-19 disease has been released by the Society of Hospital Pharmacists of Australia (SHPA) as part of an update to its bestselling Australian Injectable Drugs Handbook (AIDH) this week.
The critical need to safeguard medicines supply, as part of Australia’s national response to coronavirus, is appropriately reflected in its listing as one of 15 key triggers for the progressive shift toward a ‘COVID-safe economy’, the Society of Hospital Pharmacists of Australia (SHPA) has said today.
Society of Hospital Pharmacists of Australia (SHPA) President Peter Fowler has called coronavirus ‘a chance to be our best’, reflecting on the alarming, disruptive and unifying few months since the first confirmed local transmission of COVID-19.
